News & Updates

In individuals with obesity and moderate-to-severe pain due to knee osteoarthritis (OA), treatment with the GLP-1 RA* semaglutide led to significantly greater reductions in body weight and pain related to knee OA as opposed to placebo, findings from the STEP** 9 trial suggest.

Use of antidepressants appears to have a small beneficial effect in older adults with knee osteoarthritis (OA), but potential risks far outweigh this benefit, reports a study.

Nearly half of women with rheumatoid arthritis (RA) experience female sexual dysfunction (FSD), suggesting a link between FSD risk and RA, according to the results of a systematic review and meta-analysis. Menopause and depression status also significantly correlate with FSD in women with RA.